Outlook Therapeutics Faces a Decisive July Between the FDA and Capital Dilution
Outlook Therapeutics faces a crucial July: shareholder meeting for capital increase and FDA decision on its flagship drug. Shares rise 144% in 2026.
Latest Stock Market news
41 articles
Digi sets its IPO price at €5.6 per share, with a market capitalisation of €1.662 billion. The offer includes 51.3 million shares and a €100 million investment commitment from Grupo Mayoral.
Outlook Therapeutics faces a crucial July: shareholder meeting for capital increase and FDA decision on its flagship drug. Shares rise 144% in 2026.
The IBEX 35 falls by 2.73% to 19,104 points, its largest drop since March, due to tensions between the US and Iran and Trump's threats to Spain.
Goldman Sachs, Bankinter and Renta 4 select Indra, BBVA, Naturgy, Santander and Inditex as their top picks from the Ibex 35 for H2 2026.
Ibex 35 is flat at 19,700 points, with Logista, Inditex and Telefónica rising, while Samsung drops 7% in Seoul despite multiplying its profits.
Ibex 35 rises 0.24% to 19,730 points, driven by oil after an attack on a ship in Oman. Telefónica and Inditex lead the gains.
The Ibex 35 rises after the peace agreement between the US and Iran, led by tourism and airlines like IAG and Amadeus.
Santander surpasses Inditex as the most valuable company on the Spanish stock market, with a capitalisation exceeding €80 billion.
Naturgy accounts for 20% of Bankinter's five-value portfolio, which recommends buying with a target price of €29.80 and highlights its 6.5% dividend.
The Ibex 35 starts the week with slight declines. Indra and IAG rise, while Iberdrola and Repsol discount dividends and weigh on the index.
The Ibex 35 will distribute over €7.2 billion in dividends in July, led by Iberdrola, Endesa, and Repsol, as the index surpasses 19,800 points.
Navitas Semiconductor's shares drop 51% after a $125 million capital increase and exclusion from Russell indices, closing at €13.10.